| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 661115 | Physalin F | 0.0130238833303634 | -0.18121887 |
| NSC 672210 | Null | 0.0130238833303634 | 0.032370976 |
| NSC 683061 | Null | 0.0130238833303634 | 0.081485544 |
| NSC 699934 | Null | 0.0130238833303634 | -0.25017146 |
| NSC 701022 | Null | 0.0130238833303634 | 0.12482531 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0130238833303634 | 0.26443877 |
| NSC 711077 | Null | 0.0130238833303634 | 0.085133847 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.0130238833303634 | -0.012446638 |
| NSC 729166 | N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide | 0.0130238833303634 | -0.028324075 |
| NSC 741425 | 3,7-di(trifluoromethyl)-2-naftoylquioxaline 1,4-dioxide | 0.0130238833303634 | 0.031976796 |